Back to top
more

electroCore (ECOR)

(Real Time Quote from BATS)

$7.25 USD

7.25
50,601

+0.48 (7.09%)

Updated Aug 4, 2025 01:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 246)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?

by Zacks Equity Research

Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

electroCore (ECOR) delivered earnings and revenue surprises of 16.07% and 1.12%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

electroCore (ECOR) delivered earnings and revenue surprises of -17.65% and 3.28%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Ironwood (IRWD) delivered earnings and revenue surprises of -80% and 1.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

United Therapeutics (UTHR) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

United Therapeutics (UTHR) delivered earnings and revenue surprises of 1.48% and 1.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

electroCore (ECOR) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

electroCore (ECOR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks Equity Research

Here's Why Momentum in electroCore (ECOR) Should Keep going

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, electroCore (ECOR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Equity Research

Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Theravance Bio (TBPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

ElectroCore, Inc. (ECOR) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

electroCore (ECOR) delivered earnings and revenue surprises of -6.90% and 1.22%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sonendo, Inc. (SONXD) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Sonendo (SONXD) delivered earnings and revenue surprises of 34.29% and 1.72%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Strength Seen in electroCore (ECOR): Can Its 6.0% Jump Turn into More Strength?

by Zacks Equity Research

electroCore (ECOR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Madrigal (MDGL) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Madrigal (MDGL) delivered earnings and revenue surprises of 29.11% and 86.15%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar?

by Zacks Equity Research

electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

ElectroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

electroCore (ECOR) delivered earnings and revenue surprises of 2.56% and 4.87%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Wall Street Analysts See a 251.77% Upside in electroCore (ECOR): Can the Stock Really Move This High?

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 251.8% in electroCore (ECOR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Equity Research

Wall Street Analysts Think electroCore (ECOR) Could Surge 215.86%: Read This Before Placing a Bet

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 215.9% in electroCore (ECOR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Equity Research

Here's What Could Help electroCore (ECOR) Maintain Its Recent Price Strength

by Zacks Equity Research

electroCore (ECOR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks Equity Research

ElectroCore, Inc. (ECOR) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

electroCore (ECOR) delivered earnings and revenue surprises of -6% and 5.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Indivior PLC (INDV) Q1 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Indivior (INDV) delivered earnings and revenue surprises of -2.63% and 5.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

electroCore, Inc. (ECOR) delivered earnings and revenue surprises of -10.91% and 0.65%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Xeris Biopharma (XERS) delivered earnings and revenue surprises of -11.11% and 2.44%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of -32.56% and 87.63%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Company News for Jul 14, 2020

by Zacks Equity Research

Companies in the news are: WKHS, MXIM, BFYT, ECOR

Zacks Equity Research

ElectroCore, Inc. (ECOR) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

electroCore, Inc. (ECOR) delivered earnings and revenue surprises of -4.00% and 0.55%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for April 3rd

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 3rd